glp 1 drugs and bipolar disorder New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders GLP-1 Drugs and Eating Disorders:
Description
LIMITATIONS, REASONS FOR CAUTION Study limitations include the absence of data regarding medication compliance post prescription redemption, potential misclassification due to parallel importation, and the inability to control for unmeasured confounding factors
This is because, in the early stages of their release, there were apprehensions regarding their possible association with both pancreatitis and pancreatic cancer
Expect pricing and availability to continue shifting into 2026
Side effects like semaglutide-related symptoms should be monitored carefully during dose increases
95% CI 0.79 0.99
